Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Cedars-Sinai Medical Center · Cancer Research And Biostatistics · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
883
total citations
- FWCI
- 58.15
- Percentile
- 100%
- References
- 42
Citations per year
Authors
13Topics & keywords
Topics
Keywords
- Lenalidomide
- Dexamethasone
- Medicine
- Multiple myeloma
- Bortezomib
- Internal medicine
- Oncology
- Open label
No related works found for this paper.